Zeitschrift für klinische und experimentelle Neuroimmunologie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Synergy of Immunotherapy and Laser Interstitial Warm Treatment: Paving a Multifaceted Path in Neuro-Oncology

Gabor Jancso

The rise of immunotherapy (IT) as an oncological treatment option has significantly improved outcomes in a variety of disease states. However, due to the distinct immunologic tumor microenvironment, its application in CNS tumors is still limited for a few reasons. Accordingly, it is significant to consider the convergence of IT with extra treatment techniques that might further develop admittance to the CNS and viability of existing IT modalities. Combining IT with localized hyperthermia (HT) generated by technologies like laser interstitial thermal therapy (LITT) is one such combination. The far-reaching immunomodulatory impacts of restricted and entire body HT have been explored for quite a while. Hyperthermia has exhibited immunostimulatory impacts at the degree of cancer cells, invulnerable cells, and the more extensive climate administering possible safe reconnaissance. An exhaustive comprehension of these impacts as well as the current and forthcoming examinations of such in mix with IT is significant in considering the future headings of neuro-oncology.